Cargando…
High Dose Cyclophosphamide Treatment for Autoimmune Disorders
High-dose cyclophosphamide (200 mg/kg) was initially developed as a conditioning regimen for allogeneic bone marrow transplantation. Recently, high-dose cyclophosphamide without bone marrow transplantation has been employed as a method to induce durable treatment-free remissions in severe aplastic a...
Autor principal: | Brodsky, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009530/ https://www.ncbi.nlm.nih.gov/pubmed/12806171 http://dx.doi.org/10.1100/tsw.2002.863 |
Ejemplares similares
-
High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies
por: Mecoli, Christopher A., et al.
Publicado: (2017) -
Can propolis and caffeic acid phenethyl ester be promising agents against cyclophosphamide toxicity?
por: Akyol, Sumeyya, et al.
Publicado: (2016) -
Getting Under the Skin: Targeting Cutaneous Autoimmune Disease
por: Vesely, Matthew D.
Publicado: (2020) -
Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases
por: Ryan, Brent J., et al.
Publicado: (2014) -
Possible Association of Multicentric Castleman's Disease with Autoimmune Lymphoproliferative Syndrome
por: Minemura, Hiroyuki, et al.
Publicado: (2018)